1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
NOWTRANSIT Inc

NOWTRANSIT Inc

NOTR
NOWTRANSIT IncUS flagOther OTC
13.00
USD
- -
- -
570.91MMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.01
0.02
0.04
0.07
Basic EPS, GAAP
- -
- -
- -
-0.02
-0.04
-0.01
- -
0.01
Free Cash Flow per Basic Share
- -
- -
-0.01
-0.02
-0.04
-0.01
- -
0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
-0.01
-0.02
-0.04
-0.01
-0.01
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
0.02
0.03
Basic Weighted Avg Shares
- -
4
5
5
5
34
42
43
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
1
2
3
Operating Margin (%)
- -
- -
- -
- -
-245.81
-42.09
4.72
20.3
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
-245.81
-42.09
4.72
20.3
Working Capital
- -
- -
- -
- -
- -
- -
1
1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
1
1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
21
82.39
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'24
Dec'24
Mar'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
42
44
44
Market Capitalization
542
542
553

Working Capital

FRC

•

in mil. unless spec.
Sep'24
Dec'24
Mar'25
Total Current Assets
- -
1
1
Cash, Cash Equivalents & STI
- -
1
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-2,629.6%
-12,455.62%
Free Cash Flow
- -
111.41%
-99.07%
Net Income, GAAP
- -
95.22%
-134.59%
Sales/Revenue/Turnover
- -
- -
208.73%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1
2024
- -
- -
1
1
2
2025
1
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
-0.01
- -
- -
-0.01
2024
- -
- -
- -
- -
- -
2025
0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Darren J. Lopez
Sector
Financial Services
Industry
Shell Companies
Address
2825 East Cottonwood Parkway Salt Lake City UT United States of America 84121
IPO Date
Jun 17, 2021
CIK
0001784440
Similar Companies
Avalon Acquisition Inc. (AVAC)
Thayer Ventures Acquisition Corporation II Class A Ordinary Shares (TVAI)
Nova Vision Acquisition Corporation (NOVV)
RF Acquisition Corp II Ordinary Shares (RFAI)
Non-Invasive Monitoring Systems, Inc. (NIMU)
Reinvent Technology Partners Y (RTPYU)
Business
NOWTRANSIT Inc (NOTR), a Nevada corporation founded on July 8, 2019 and headquartered at 2722 South West Temple, Salt Lake City, UT 84115, develops, markets and sells clinically-tested, affordably priced health supplements targeting bacteria, viruses, allergens, brain health and mitochondrial support primarily through online platforms including its websites and Amazon Seller Central, as well as other distribution channels serving consumers in the United States. Core products include Be On-Guard Mouth Spray and Nasal Spray for oral and nasal defense against bacteria, viruses and allergens; Be On-Guard Brain Fog Support; ADHD 365 maximum strength brain support; EZ Safer Surface Cleaner and EZ Safer Air for airborne and surface protection; NeuroPro Plus, a patent-pending pharmaceutical-grade methylene blue and vitamin C combination; TBI-365 blending methylene blue, glycine, NAC and niacinamide for brain health; and Metabolism+ for metabolic enhancement, with market focus spanning dementia/Alzheimer's, ADHD/ADD, Long Covid, energy boosting, traumatic brain injury, cognitive decline, GLP-1 weight loss, sleep improvement, epilepsy/seizure reduction and nasal/allergy relief. The company completed a reverse merger on March 10, 2023 acquiring Best 365 Labs Inc as a wholly-owned subsidiary in exchange for 34,371,100 common shares representing 85.39% ownership, shifting from prior online delivery plans to immune and wellness products; issued 1,063,621 common shares for $265,000 in 2023 and 3,020,000 shares for $755,000 in 2024 alongside a $1 million private placement to accredited investors; filed provisional patents on methylene blue formulations; amended its Restated Certificate of Incorporation on February 21, 2025; reported $1.84 million in 2024 revenue versus $598,000 in 2023 with net income of $87,000 after prior losses; and recently changed ticker to BHIC as BioScience Health Innovations Inc while actively pursuing partnerships, strategic alliances and a Form 1-A filing with the SEC to expand mental health and wellness segments.